Literature DB >> 16837048

Nuclear receptors in human immune cells: expression and correlations.

Andrea B Schote1, Jonathan D Turner, Jang Schiltz, Claude P Muller.   

Abstract

Nuclear receptors (NR) are key modulators of gene transcription. Their activity is ligand induced and modulates a large variety of tissue-specific cellular functions. However, for many NR little is known about their role in cells of the immune system. In this study, expression patterns and distribution of 24 NR were investigated in human peripheral blood mononuclear cells. We provide the first evidence of the expression of the 12 receptors CAR, CoupTFalpha, CoupTFbeta, FXR, GCNF, HNF4alpha, PPARbeta/delta, PXR, RevErbbeta, TR2, TR4 and TLX in highly purified CD4, CD8, CD19, CD14 cells. The expression profile of RevErbalpha and LXRalpha previously observed in B cell and macrophages, respectively, has been extended to CD4, CD8 and CD14 cells. Except for RARbeta, which was absence in any of the cells tested, our results suggest an almost ubiquitous expression of the NR in the different cell lineages of the immune system. The expression of CAR, CoupTFalpha, FXR was also confirmed at a protein level and despite conspicuous mRNA levels of HNF4alpha, only low levels of this receptor were detectable in the nuclear fraction of PBMCs. Expression of the latter receptors was mostly only a fraction (4-20%) of their expression in the thyroid gland, the adrenal gland, the lung or subcutaneous adipose tissue. The Spearman rank order correlation test was performed to examine the correlation in expression between individual nuclear receptor pairs in the four cell types for several donors. Distinct correlation patterns were observed between receptor pairs in the individual cell types. In CD4 T cells four NR, GCNF, PPARgamma, PPARalpha7 and RevErbbeta are perfectly correlated with each other (P> or =0.0167). In the other cell types correlations between NR pairs were more diverse, but also statistically highly significant. Interestingly, the relative expression level of a number of receptor pairs ranked identical or similar in at least three (CoupTFalpha and PPARbeta/delta, CoupTFbeta and HNF4alpha as well as RORbeta and PXR) or four cell types (CoupTFalpha and CoupTFbeta, PPARgamma and RevErbbeta). Despite the variability of NR expression in immune cells, these results suggest that some of the NR may be co-regulated in human immune cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16837048     DOI: 10.1016/j.molimm.2006.04.021

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  51 in total

1.  SHP-dependent and -independent induction of peroxisome proliferator-activated receptor-γ by the bile acid sensor farnesoid X receptor counter-regulates the pro-inflammatory phenotype of liver myofibroblasts.

Authors:  Barbara Renga; Andrea Mencarelli; Marco Migliorati; Sabrina Cipriani; Claudio D'Amore; Eleonora Distrutti; Stefano Fiorucci
Journal:  Inflamm Res       Date:  2011-01-29       Impact factor: 4.575

Review 2.  Microbiome, bile acids, and obesity: How microbially modified metabolites shape anti-tumor immunity.

Authors:  Laura M Sipe; Mehdi Chaib; Ajeeth K Pingili; Joseph F Pierre; Liza Makowski
Journal:  Immunol Rev       Date:  2020-05       Impact factor: 12.988

Review 3.  Sulfotransferase genes: regulation by nuclear receptors in response to xeno/endo-biotics.

Authors:  Susumu Kodama; Masahiko Negishi
Journal:  Drug Metab Rev       Date:  2013-09-11       Impact factor: 4.518

4.  B-1 cell lymphoma in mice lacking the steroid and xenobiotic receptor, SXR.

Authors:  Stephanie C Casey; Edward L Nelson; Gina M Turco; Matthew R Janes; David A Fruman; Bruce Blumberg
Journal:  Mol Endocrinol       Date:  2011-03-24

5.  Bile Acid Receptors and Gastrointestinal Functions.

Authors:  Alexander L Ticho; Pooja Malhotra; Pradeep K Dudeja; Ravinder K Gill; Waddah A Alrefai
Journal:  Liver Res       Date:  2019-01-14

Review 6.  Intestinal Absorption of Bile Acids in Health and Disease.

Authors:  Alexander L Ticho; Pooja Malhotra; Pradeep K Dudeja; Ravinder K Gill; Waddah A Alrefai
Journal:  Compr Physiol       Date:  2019-12-18       Impact factor: 9.090

Review 7.  Pregnane X receptor as a target for treatment of inflammatory bowel disorders.

Authors:  Jie Cheng; Yatrik M Shah; Frank J Gonzalez
Journal:  Trends Pharmacol Sci       Date:  2012-05-18       Impact factor: 14.819

8.  Use of human bronchial epithelial cells (BEAS-2B) to study immunological markers resulting from exposure to PM(2.5) organic extract from Puerto Rico.

Authors:  Enrique Fuentes-Mattei; Evasomary Rivera; Adriana Gioda; Diana Sanchez-Rivera; Felix R Roman-Velazquez; Braulio D Jimenez-Velez
Journal:  Toxicol Appl Pharmacol       Date:  2009-12-21       Impact factor: 4.219

Review 9.  The impact of farnesoid X receptor activation on intestinal permeability in inflammatory bowel disease.

Authors:  Maja Stojancevic; Karmen Stankov; Momir Mikov
Journal:  Can J Gastroenterol       Date:  2012-09       Impact factor: 3.522

Review 10.  The pregnane X receptor in tuberculosis therapeutics.

Authors:  Amina I Shehu; Guangming Li; Wen Xie; Xiaochao Ma
Journal:  Expert Opin Drug Metab Toxicol       Date:  2015-12-05       Impact factor: 4.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.